RightFit
RecruitingNot applicable

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Travel or expenses covered

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 6 months

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months."
Compensation
Travel or expenses covered
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This 6-month study tests adding a continuous glucose monitor (CGM), a device that tracks blood sugar, to diabetes education sent by text message. It is for people with type 2 diabetes who do not use insulin.

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have type 2 diabetes.
  • Do not currently use a continuous glucose monitor (CGM).
  • Do not use insulin.
  • Speak English, Spanish, or Arabic.
  • Had an A1c result between 7.5% and 12.0% in the past 90 days. A1c measures average blood sugar over about 3 months.
  • Have a cellphone that can send and receive text messages and count steps.

Who can't join

  • Use insulin.
  • Are pregnant.
  • Currently use a continuous glucose monitor (CGM).
  • Are taking part in another diabetes-related study.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Diagnosed with type 2 diabetes * Are not currently using a CGM * Are not using insulin therapies * Speak English, Spanish or Arabic * Have A1c between 7.5% and 12.0% in last 90 days * Have a cellphone that can receive/send text messages and counts steps Exclusion Criteria: * Are using insulin therapies * Are pregnant * Are currently using a CGM * Are currently participating in another diabetes-related study

Study sites (1)

CA